Companion Article for The Business of Cancer Care: What Survival Costs in America’s Cancer Economy… and why the patient still comes last
As I was writing the column listed above, another question kept surfacing: If AI can synthesize enormous volumes of information, what kind of healthcare system would it recommend for the United States?
AI is not a person, a conscience, or a substitute for judgment. It is a tool trained on vast amounts of public and licensed material, and its usefulness depends on how it is built, what data it can access, and the assumptions embedded in its design. Even so, it can be useful for framing difficult policy questions.
So I asked a simple question: What would be the best alternative healthcare solution for the United States? Continue reading

Mark Cuban thinks America’s health care system can somehow turn the exact same MRI machine into a luxury item depending on which building a patient walks into.
COLUMBUS, Ohio
A pro-lifer says lawmakers are trying to prevent the federal government from getting specific information about things such as abortion.
Billionaire Mark Cuban says big drug and insurance companies in the U.S. have grown too powerful to care about ordinary people, but policymakers aren’t taking any real action to fix it.
We’re supposed to believe that medical licensing exists to protect healthcare consumers from “quacks” and “charlatans.” The purpose, we’re told, is to improve the quality of healthcare, yet this system has manifestly failed to produce good patient outcomes.
Billionaire entrepreneur Mark Cuban isn’t letting the absurdity of America’s healthcare costs slide – not when a scan can cost more than some used cars.
The modern American health insurance system didn’t emerge because someone designed it thoughtfully, and it shows. It evolved from a series of political, economic, and cultural accidents beginning largely around the period of World War II. As with many political redistribution schemes, once underway, the system has snowballed into the unsustainable trajectory we see today.

The FDA said that a generic version of metoprolol was recalled because it failed to meet the agency’s criteria. (Oh GOODY – My Heart Doctah has this stuff prescribed to me! –
President Trump on Tuesday announced that Pfizer had agreed to sell its products in the U.S. at “Most Favored Nation” pricing, one day after the administration required companies to respond to his prescription drug pricing executive order.